We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+8.36%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$6.69B
AUM Growth
+$10.4M
Cap. Flow
-$380M
Cap. Flow %
-5.67%
Top 10 Hldgs %
22.1%
Holding
2,631
New
97
Increased
574
Reduced
1,704
Closed
44

Sector Composition

Rank Sector Weight
1 Technology 22.89%
2 Healthcare 12.85%
3 Financials 12.46%
4 Consumer Discretionary 12.34%
5 Industrials 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNDX icon
2101
Syndax Pharmaceuticals
SNDX
$1.7B
$177K ﹤0.01%
7,930
NPK icon
2102
National Presto Industries
NPK
$987M
$177K ﹤0.01%
1,737
MNKD icon
2103
MannKind Corp
MNKD
$1.2B
$177K ﹤0.01%
45,138
-17,745
-28% -$72.8K
FFG
2104
DELISTED
FBL Financial Group
FFG
$177K ﹤0.01%
3,158
IGMS
2105
DELISTED
IGM Biosciences
IGMS
$177K ﹤0.01%
2,302
LOVE
2106
LoveSac
LOVE
$258M
$177K ﹤0.01%
3,119
SPRY icon
2107
ARS Pharmaceuticals
SPRY
$606M
$176K ﹤0.01%
+4,038
New +$191K
THFF icon
2108
First Financial Corp
THFF
$975M
$176K ﹤0.01%
3,912
AVD icon
2109
American Vanguard Corp
AVD
$62.8M
$176K ﹤0.01%
8,624
+614
+8% +$11.7K
OM icon
2110
Outset Medical
OM
$79.9M
$176K ﹤0.01%
216
VERI icon
2111
Veritone
VERI
$139M
$176K ﹤0.01%
7,336
GBT
2112
DELISTED
Global Blood Therapeutics, Inc.
GBT
$176K ﹤0.01%
4,313
-195
-4% -$8.96K
TCRR
2113
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$176K ﹤0.01%
7,958
RETA
2114
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$175K ﹤0.01%
1,756
+74
+4% +$8.63K
ASTH icon
2115
Astrana Health
ASTH
$1.87B
$175K ﹤0.01%
6,462
HSTM icon
2116
HealthStream
HSTM
$849M
$175K ﹤0.01%
7,834
-642
-8% -$15.3K
VST icon
2117
Vistra
VST
$49.1B
$175K ﹤0.01%
9,882
+382
+4% +$7.59K
ARMK icon
2118
Aramark
ARMK
$16.1B
$175K ﹤0.01%
6,401
+246
+4% +$6.74K
WMK icon
2119
Weis Markets
WMK
$1.77B
$174K ﹤0.01%
3,080
VOR icon
2120
Vor Biopharma
VOR
$1.38B
$174K ﹤0.01%
+202
New +$171K
FWONK icon
2121
Liberty Media Series C
FWONK
$26B
$174K ﹤0.01%
4,152
+162
+4% +$6.85K
FRO icon
2122
Frontline
FRO
$9.02B
$174K ﹤0.01%
24,274
-7,716
-24% -$53.2K
MLCO icon
2123
Melco Resorts & Entertainment
MLCO
$2.14B
$173K ﹤0.01%
8,700
ECVT icon
2124
Ecovyst
ECVT
$1.1B
$173K ﹤0.01%
10,351
-1,139
-10% -$18.1K
WSBF icon
2125
Waterstone Financial
WSBF
$385M
$173K ﹤0.01%
8,456
-732
-8% -$14.5K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q1 2021 Portfolio in Review

As of Q1 2021, Metropolitan Life Insurance Company (MetLife) held 2,631 positions worth $6.69B, up 0.16% from $6.68B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $380M in Q1 2021, closing 44 positions and reducing 1,704 holdings. Its most notable exit was Tiffany & Co., an estimated $1.87M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in NXP Semiconductors worth $5.75M.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q1 2021 buy was NXP Semiconductors: 28,567 shares worth $5.75M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares Russell 2000 ETF in Q1 2021, an estimated $12.4M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $108M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Tiffany & Co. in Q1 2021, selling an estimated $1.87M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 22% of its $6.69B portfolio in Q1 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 97 new positions and closed 44 in Q1 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 0.16% quarter-over-quarter to $6.69B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2021, filed 14 May 2021.